Encephalocraniocutaneous lipomatosis (ECCL) is a rare neurocutaneous syndrome that include skin, ocular, and neurological disorders. This study describes the case of a 16-year-old girl that came to observation for the treatment of a congenital alopecia causing great psychological distress. After two expansion procedures the hairless patch was restored with high patient satisfaction. The case met all the criteria for definite diagnosis of ECCL.

Download full-text PDF

Source
http://dx.doi.org/10.3109/2000656X.2013.842293DOI Listing

Publication Analysis

Top Keywords

encephalocraniocutaneous lipomatosis
8
congenital alopecia
8
rare neurocutaneous
8
neurocutaneous syndrome
8
lipomatosis congenital
4
alopecia treatment
4
treatment rare
4
syndrome encephalocraniocutaneous
4
lipomatosis eccl
4
eccl rare
4

Similar Publications

We report a patient with clinically confirmed Schimmelpenning-Feuerstein-Mims (SFM) syndrome but many overlapping features with oculoectodermal syndrome (OES) and encephalocraniocutaneous lipomatosis (ECCL). Whole exome sequencing revealed a mosaic KRAS c.436G>A, p.

View Article and Find Full Text PDF
Article Synopsis
  • Encephalocraniocutaneous lipomatosis (ECCL), or Haberland syndrome, is a rare condition affecting the skin, central nervous system, and eyes, characterized by tumors and other abnormalities.
  • Key symptoms include specific skin lesions, subcutaneous lipomas, and neurological issues like intracranial lipomas and developmental delays.
  • Diagnosis primarily relies on clinical evaluation with possible genetic testing; management is multidisciplinary, focusing on symptom relief and monitoring for potential complications.
View Article and Find Full Text PDF

A Hemorrhagic Brain Mass in a Child With Encephalocraniocutaneous Lipomatosis.

J Pediatr Hematol Oncol

October 2024

Division of Hematology, Oncology, and Bone Marrow Transplant, Department of Pediatrics, Seattle Children's Hospital.

Article Synopsis
  • Encephalocraniocutaneous lipomatosis (ECCL) is a rare genetic disorder characterized by specific skin, eye, and brain abnormalities.
  • There have been case reports linking ECCL to low-grade gliomas and certain mutations in the FGFR1 gene.
  • This report highlights a patient with ECCL who has a diffuse low-grade glioma and a unique FGFR1 mutation that affects the mitogen activated protein kinase pathway.
View Article and Find Full Text PDF
Article Synopsis
  • Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome that affects the eyes, skin, and central nervous system, linked to specific genetic variants.
  • A case study of a patient with Neurofibromatosis type 1 revealed a germline pathogenic variant associated with ECCL, suggesting a broader relationship between these conditions.
  • Genetic analysis indicated biallelic inactivation happening early in embryonic development, which could explain the severe abnormalities typical of ECCL, activating the RAS-MAPK pathway and demonstrating different forms of mosaicism contributing to the phenotype.
View Article and Find Full Text PDF

Encephalocraniocutaneous lipomatosis (ECCL) is a rare congenital syndrome and subclassification of oculoectodermal syndrome. Encephalocraniocutaneous lipomatosis may be associated with postzygotic mutations. However, absence of an identifiable mutation does not preclude a diagnosis of ECCL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!